Literature DB >> 30443663

Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode.

Jessica Scharrenbroich1, Volkhard Kaever2, Stefan Dove3, Roland Seifert1, Erich H Schneider4.   

Abstract

The non-canonical cyclic nucleotide cUMP and the phosphodiesterase PDE9A both occur in neuronal cells. Using HPLC-coupled tandem mass spectrometry, we characterized the kinetics of PDE9A-mediated cUMP hydrolysis. PDE9A is a low-affinity and high-velocity enzyme for cUMP (Vmax = ~ 6 μmol/min/mg; Km = ~ 401 μM). The PDE9 inhibitor BAY 73-6691 inhibited PDE9A-catalyzed cUMP hydrolysis (Ki = 590 nM). Docking studies indicate two H-bonds between the cUMP uridine moiety and Gln453/Asn405 of PDE9A. By contrast, the guanosine moiety of cGMP forms three H-bonds with Gln453. cCMP is not hydrolyzed at a concentration of 3 μM, but inhibits the PDE9A-catalyzed cUMP hydrolysis at concentrations of 100 μM or more. The probable main reason is that the cytosine moiety cannot act as H-bond acceptor for Gln453. A comparison of PDE9A with PDE7A suggests that the preference of the former for cGMP and cUMP and of the latter for cAMP and cCMP is due to stabilized alternative conformations of the side chain amide of Gln453 and Gln413, respectively. This so-called glutamine switch is known to be involved in the regulation of cAMP/cGMP selectivity of some PDEs.

Entities:  

Keywords:  Cyclic CMP; Cyclic UMP; Enzyme kinetics; Glutamine switch; PDE9A; Phosphodiesterase

Mesh:

Substances:

Year:  2018        PMID: 30443663     DOI: 10.1007/s00210-018-1582-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line.

Authors:  Frank Wunder; Adrian Tersteegen; Annegret Rebmann; Christina Erb; Thomas Fahrig; Martin Hendrix
Journal:  Mol Pharmacol       Date:  2005-09-08       Impact factor: 4.436

2.  cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: High cCMP and cUMP levels in astrocytes.

Authors:  Christina Hartwig; Heike Bähre; Sabine Wolter; Ulrike Beckert; Volkhard Kaever; Roland Seifert
Journal:  Neurosci Lett       Date:  2014-07-23       Impact factor: 3.046

3.  Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.

Authors:  Heike Bähre; Kerstin Y Danker; Johannes-Peter Stasch; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2013-12-28       Impact factor: 3.575

Review 4.  Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel activity by cCMP.

Authors:  Xiangang Zong; Stefanie Krause; Cheng-Chang Chen; Jens Krüger; Christian Gruner; Xiaochun Cao-Ehlker; Stefanie Fenske; Christian Wahl-Schott; Martin Biel
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

6.  Structural insight into substrate specificity of phosphodiesterase 10.

Authors:  Huanchen Wang; Yudong Liu; Jing Hou; Meiyan Zheng; Howard Robinson; Hengming Ke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-26       Impact factor: 11.205

7.  Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain.

Authors:  W C G van Staveren; J Glick; M Markerink-van Ittersum; M Shimizu; J A Beavo; H W M Steinbusch; J de Vente
Journal:  J Neurocytol       Date:  2002 Sep-Nov

8.  ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation.

Authors:  Urike Beckert; Sabine Wolter; Christina Hartwig; Heike Bähre; Volkhard Kaever; Daniel Ladant; Dara W Frank; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2014-06-24       Impact factor: 3.575

9.  Central action of cyclic: 3',5'-thymidine, 3',5'-uridine and 3',5'-citidine monophosphates in rat.

Authors:  R Brus; Z S Herman; Z Juraszczyk; T Krzemiński; H Trzeciak; A Kurcok
Journal:  Acta Med Pol       Date:  1984

10.  The Pseudomonas aeruginosa ExoY phenotype of high-copy-number recombinants is not detectable in natural isolates.

Authors:  Antje Munder; Justin Rothschuh; Bastian Schirmer; Jens Klockgether; Volkhard Kaever; Burkhard Tümmler; Roland Seifert; Christina Kloth
Journal:  Open Biol       Date:  2018-01       Impact factor: 6.411

View more
  1 in total

1.  Apoptotic and anti-proliferative effect of guanosine and guanosine derivatives in HuT-78 T lymphoma cells.

Authors:  Erich H Schneider; Olga Hofmeister; Solveig Kälble; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-04-20       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.